Your browser doesn't support javascript.
A Retrospective Analysis of Perioperative Chemotherapy and Coronavirus Disease in Patients With Breast Cancer.
Hayashi, Kazumi; Tamura, Miho; Nagasaki, Eijiro; Yoshii, Yukiko; Ishigaki, Takayuki; Kazama, Takashi; Kamio, Makiko; Nogi, Hiroko; Toriumi, Yasuo; Takeyama, Hiroshi; Yano, Shingo.
  • Hayashi K; Department of Clinical Oncology and Hematology, The Jikei University School of Medicine, Tokyo, Japan; kz.hayashi@gmai.com.
  • Tamura M; Department of Clinical Oncology and Hematology, The Jikei University School of Medicine, Tokyo, Japan.
  • Nagasaki E; Department of Clinical Oncology and Hematology, The Jikei University School of Medicine, Tokyo, Japan.
  • Yoshii Y; Department of Breast and Endocrine Surgery, The Jikei University School of Medicine, Tokyo, Japan.
  • Ishigaki T; Department of Breast and Endocrine Surgery, The Jikei University School of Medicine, Tokyo, Japan.
  • Kazama T; Department of Breast and Endocrine Surgery, The Jikei University School of Medicine, Tokyo, Japan.
  • Kamio M; Department of Breast and Endocrine Surgery, The Jikei University School of Medicine, Tokyo, Japan.
  • Nogi H; Department of Breast and Endocrine Surgery, The Jikei University School of Medicine, Tokyo, Japan.
  • Toriumi Y; Department of Breast and Endocrine Surgery, The Jikei University School of Medicine, Tokyo, Japan.
  • Takeyama H; Department of Breast and Endocrine Surgery, The Jikei University School of Medicine, Tokyo, Japan.
  • Yano S; Department of Clinical Oncology and Hematology, The Jikei University School of Medicine, Tokyo, Japan.
Anticancer Res ; 41(4): 2193-2195, 2021 Apr.
Article in English | MEDLINE | ID: covidwho-1168334
ABSTRACT
BACKGROUND/

AIM:

Since January 2020, coronavirus disease (COVID-19) cases have been confirmed in Japan, and the number of patients with COVID-19 has been increasing. Two emergency declarations have been made previously and one is currently in effect. Based on our experience of a situation that could affect cancer treatment, this study retrospectively examined the correlation between perioperative anticancer therapy and COVID-19 incidence in patients with breast cancer. PATIENTS AND

METHODS:

Patients who underwent perioperative anticancer therapy for breast cancer at our hospital from February 2020 to February 2021 were included in this study. The presence or absence of COVID-19, timing of anticancer drug initiation, and clinical data were collected.

RESULTS:

No cases of COVID-19 were diagnosed in patients receiving perioperative anticancer therapy at our hospital.

CONCLUSION:

Regimen modification, active use of supportive care, and patient lifestyle were factors reducing the incidence of COVID-19.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Perioperative Care / COVID-19 Type of study: Observational study / Prognostic study Limits: Aged / Female / Humans / Middle aged Country/Region as subject: Asia Language: English Journal: Anticancer Res Year: 2021 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Perioperative Care / COVID-19 Type of study: Observational study / Prognostic study Limits: Aged / Female / Humans / Middle aged Country/Region as subject: Asia Language: English Journal: Anticancer Res Year: 2021 Document Type: Article